Lab-based IVD Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics [Enzyme-Linked Immunosorbent Assay, Fluorescence Immunoassay, Rapid Test], Clinical Chemistry [Electrolyte Panel, Basic & Comprehensive Metabolic Panels, Liver Tests], Molecular Diagnostics [PCR, In Situ Hybridization], Hematology), By Sample Type (Blood, Urine, Saliva, Tissue), By Application (Infectious Diseases, Cardiology, Oncology), By End-user (Hospitals, Clinical Laboratories), & Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI112985

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, by Key Countries/Sub-regions, 2023/2024
2. Technological Advancements in Lab-based IVD Products
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Abbott
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Sysmex Corporation
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. Siemens Healthineers AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. BD
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. QIAGEN
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  8. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  9. Seegene Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  10. DiaSorin S.p.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  11. Quest Diagnostics Incorporated
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, by Key Countries/Sub-regions, 2023/2024
2. Technological Advancements in Lab-based IVD Products
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Lab-based IVD Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
    1. Enzyme-Linked Immunosorbent Assay (ELISA)
    2. Fluorescence immunoassay (FIA)
    3. Rapid test
    4. Others
  2. Clinical Chemistry
    1. Electrolyte Panel
    2. Basic and Comprehensive Metabolic Panels
    3. Liver Tests
    4. Renal Tests
    5. Lipid Panel
    6. Others
  3. Molecular Diagnostics
    1. Polymerase Chain Reaction (PCR)
    2. In Situ Hybridization
    3. DNA Sequencing & Next-Generation Sequencing
    4. Others
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Urine
  3. Saliva
  4. Tissue
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Allergy
  6. Autoimmunity
  7. Prenatal Screening
  8. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Abbott
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Sysmex Corporation
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. Siemens Healthineers AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. BD
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. QIAGEN
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  8. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  9. Seegene Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  10. DiaSorin S.p.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  11. Quest Diagnostics Incorporated
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Read Less

List of Figures

Figure 1: Global Lab-based IVD Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Lab-based IVD Market Value Share (%), by Product Type, 2024 & 2032

Figure 3: Global Lab-based IVD Market Value Share (%), by Technique, 2024 & 2032

Figure 4: Global Lab-based IVD Market Value Share (%), by Sample Type 2024 & 2032

Figure 5: Global Lab-based IVD Market Value Share (%), by Application, 2024 & 2032

Figure 6: Global Lab-based IVD Market Value Share (%), by End-user, 2024 & 2032

Figure 7: Global Lab-based IVD Market Value (USD billion), by Region, 2024 & 2032

Figure 8: North America Lab-based IVD Market Value (USD billion), by Product Type, 2024 & 2032

Figure 9: North America Lab-based IVD Market Value Share (%), by Product Type, 2024

Figure 10: North America Lab-based IVD Market Value (USD billion), by Technique, 2024 & 2032

Figure 11: North America Lab-based IVD Market Value Share (%), by Technique, 2024

Figure 12: North America Lab-based IVD Market Value (USD billion), by Sample Type, 2024 & 2032

Figure 13: North America Lab-based IVD Market Value Share (%), by Sample Type, 2024

Figure 14: North America Lab-based IVD Market Value (USD billion), by Application, 2024 & 2032

Figure 15: North America Lab-based IVD Market Value Share (%), by Application, 2024

Figure 16: North America Lab-based IVD Market Value (USD billion), by End-user, 2024 & 2032

Figure 17: North America Lab-based IVD Market Value Share (%), by End-user, 2024

Figure 18: North America Lab-based IVD Market Value (USD billion), By Country, 2024 & 2032

Figure 19: North America Lab-based IVD Market Value Share (%), By Country, 2024

Figure 20: Europe Lab-based IVD Market Value (USD billion), by Product Type, 2024 & 2032

Figure 21: Europe Lab-based IVD Market Value Share (%), by Product Type, 2024

Figure 22: Europe Lab-based IVD Market Value (USD billion), by Technique, 2024 & 2032

Figure 23: Europe Lab-based IVD Market Value Share (%), by Technique, 2024

Figure 24: Europe Lab-based IVD Market Value (USD billion), by Sample Type, 2024 & 2032

Figure 25: Europe Lab-based IVD Market Value Share (%), by Sample Type, 2024

Figure 26: Europe Lab-based IVD Market Value (USD billion), by Application, 2024 & 2032

Figure 27: Europe Lab-based IVD Market Value Share (%), by Application, 2024

Figure 28: Europe Lab-based IVD Market Value (USD billion), by End-user, 2024 & 2032

Figure 29: Europe Lab-based IVD Market Value Share (%), by End-user, 2024

Figure 30: Europe Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 31: Europe Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2024

Figure 32: Asia Pacific Lab-based IVD Market Value (USD billion), by Product Type, 2024 & 2032

Figure 33: Asia Pacific Lab-based IVD Market Value Share (%), by Product Type, 2024

Figure 34: Asia Pacific Lab-based IVD Market Value (USD billion), by Technique, 2024 & 2032

Figure 35: Asia Pacific Lab-based IVD Market Value Share (%), by Technique, 2024

Figure 36: Asia Pacific Lab-based IVD Market Value (USD billion), by Sample Type, 2024 & 2032

Figure 37: Asia Pacific Lab-based IVD Market Value Share (%), by Sample Type, 2024

Figure 38: Asia Pacific Lab-based IVD Market Value (USD billion), by Application, 2024 & 2032

Figure 39: Asia Pacific Lab-based IVD Market Value Share (%), by Application, 2024

Figure 40: Asia Pacific Lab-based IVD Market Value (USD billion), by End-user, 2024 & 2032

Figure 41: Asia Pacific Lab-based IVD Market Value Share (%), by End-user, 2024

Figure 42: Asia Pacific Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 43: Asia Pacific Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2024

Figure 44: Latin America Lab-based IVD Market Value (USD billion), by Product Type, 2024 & 2032

Figure 45: Latin America Lab-based IVD Market Value Share (%), by Product Type, 2024

Figure 46: Latin America Lab-based IVD Market Value (USD billion), by Technique, 2024 & 2032

Figure 47: Latin America Lab-based IVD Market Value Share (%), by Technique, 2024

Figure 48: Latin America Lab-based IVD Market Value (USD billion), by Sample Type, 2024 & 2032

Figure 49: Latin America Lab-based IVD Market Value Share (%), by Sample Type, 2024

Figure 50: Latin America Lab-based IVD Market Value (USD billion), by Application, 2024 & 2032

Figure 51: Latin America Lab-based IVD Market Value Share (%), by Application, 2024

Figure 52: Latin America Lab-based IVD Market Value (USD billion), by End-user, 2024 & 2032

Figure 53: Latin America Lab-based IVD Market Value Share (%), by End-user, 2024

Figure 54: Latin America Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 55: Latin America Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2024

Figure 56: Middle East & Africa Lab-based IVD Market Value (USD billion), by Product Type, 2024 & 2032

Figure 57: Middle East & Africa Lab-based IVD Market Value Share (%), by Product Type, 2024

Figure 58: Middle East & Africa Lab-based IVD Market Value (USD billion), by Technique, 2024 & 2032

Figure 59: Middle East & Africa Lab-based IVD Market Value Share (%), by Technique, 2024

Figure 60: Middle East & Africa Lab-based IVD Market Value (USD billion), by Sample Type, 2024 & 2032

Figure 61: Middle East & Africa Lab-based IVD Market Value Share (%), by Sample Type, 2024

Figure 62: Middle East & Africa Lab-based IVD Market Value (USD billion), by Application, 2024 & 2032

Figure 63: Middle East & Africa Lab-based IVD Market Value Share (%), by Application, 2024

Figure 64: Middle East & Africa Lab-based IVD Market Value (USD billion), by End-user, 2024 & 2032

Figure 65: Middle East & Africa Lab-based IVD Market Value Share (%), by End-user, 2024

Figure 66: Middle East & Africa Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 67: Middle East & Africa Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2024

Figure 68: Global Lab-based IVD Market Share (%), By Company, 2024

List of Tables

Table 1: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019–2032

Table 2: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 3: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 4: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 5: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 6: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 7: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 8: Global Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 9: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 10: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 11: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 12: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 13: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 14: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 15: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 16: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 17: North America Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 18: North America Lab-based IVD Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 19: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 20: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 21: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 22: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 23: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 24: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 25: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 26: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 27: Europe Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 28: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 29: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 30: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 31: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 32: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 33: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 34: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 35: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 36: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 37: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 38: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 39: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 40: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 41: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 42: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 43: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 44: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 45: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 46: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 47: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 48: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2019–2032

Table 49: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2019–2032

Table 50: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019–2032

Table 51: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2019–2032

Table 52: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 53: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 54: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 140

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com